OverviewChartNewsTraderScreen

GARO AB/  SE0015812417  /

Stuttgart
2024-05-06  2:02:57 PM Chg. +0.080 Volume Bid6:21:23 PM Ask6:21:23 PM High Low
2.630EUR +3.14% -
Turnover: -		 2.635Bid Size: 420 2.685Ask Size: 410 2.630 2.565
GlobeNewswire 2022-03-07 Targovax ASA and Agenus announce collaboration on mutant KRAS cancer vaccine adjuvanted with QS-21 S...
GlobeNewswire 2021-11-17 Agenus to Participate in 4th Annual Evercore ISI HealthCONx Conference
GlobeNewswire 2021-11-16 Protagenic Therapeutics Announces Third Quarter 2021 Results and Business Update
GlobeNewswire 2021-11-09 Agenus Corporate Update and Third Quarter 2021 Financial Report
GlobeNewswire 2021-10-22 Agenus Provides Update on Balstilimab Development
GlobeNewswire 2021-09-10 New Agenus Subsidiary, SaponiQx, Builds Innovative Adjuvant Platform and Forms Collaboration with Gi...
GlobeNewswire 2021-08-17 Protagenic Therapeutics Announces Second Quarter 2021 Results and Provides Business Update
GlobeNewswire 2021-08-09 Agenus Corporate Update and Second Quarter 2021 Financial Report
GlobeNewswire 2021-07-10 Agenus Acquires 120 Acres in the Heart of the California Biomanufacturing Center in Vacaville
GlobeNewswire 2021-07-06 Agenus Closes $200M Upfront BMS Collaboration and Announces FDA Acceptance of IND for Partnered Anti...
GlobeNewswire 2021-05-18 Agenus and Bristol Myers Squibb Announce Exclusive Global License for Agenus’ Anti-TIGIT Bispecific ...
GlobeNewswire 2021-05-06 Agenus Corporate Update and First Quarter 2021 Financial Report
GlobeNewswire 2021-03-15 Progress Software to Report First Quarter Financial Results on March 25, 2021
GlobeNewswire 2021-03-15 Agenus Corporate Update and Fourth Quarter & Full Year 2020 Financial Report
GlobeNewswire 2021-02-09 Andy Hurley Named Agenus Chief Commercial Officer
GlobeNewswire 2021-02-04 Agenus Announces Positive Preliminary Results of iNKT Cell Therapy Trial in COVID-19
GlobeNewswire 2021-01-14 Progress Reports 2020 Fiscal Fourth Quarter and Year End Results
GlobeNewswire 2021-01-04 Progress Software to Report Financial Results for Fiscal Fourth Quarter and Fiscal 2020 on January 1...
GlobeNewswire 2020-12-16 Dr. Maurizio Fava of Massachusetts General Hospital to Serve as Principal Investigator for PT00114 C...
GlobeNewswire 2020-11-10 An Agenus-discovered first-in-class ILT4 antibody, MK-4830, enters Phase 2
GlobeNewswire 2020-11-05 Dr. Steven O’Day Named Agenus Chief Medical Officer
GlobeNewswire 2020-11-02 Agenus Doses First COVID-19 Patient with iNKT Cell Therapy
GlobeNewswire 2020-10-13 Susan Hirsch Joins Agenus’ Board of Directors
GlobeNewswire 2020-09-29 Progress Announces Third Quarter 2020 Financial Results
GlobeNewswire 2020-09-22 Progress Software Announces Details for Fiscal Third Quarter Earnings Release and Conference Call